Source: Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals Blog Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results

CORAL GABLES, Fla., March 15, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Catalyst Pharmaceuticals's latest SEC filings

Annual Revenue

Based on data from Catalyst Pharmaceuticals's latest SEC filings

Employees

Patrick J. McEnany's photo - Chairman & CEO of Catalyst Pharmaceuticals

Chairman & CEO

Patrick J. McEnany

CEO Approval Rating

72/100

Catalyst is a specialty pharmaceutical company focused on in-licensing and developing.

Catalyst Pharmaceuticals's headqua...
Read more